Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Levetiracetam NDC 27241-008 by Ajanta Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

levetiracetam-fig1 - levetiracetam fig1

levetiracetam-fig1 - levetiracetam fig1

This appears to be a list showing percentages of patients, with varying values ranging from 0% up to 185%. It's unclear what the percentages represent without additional context.*

levetiracetam-fig2 - levetiracetam fig2

levetiracetam-fig2 - levetiracetam fig2

levetiracetam-fig3 - levetiracetam fig3

levetiracetam-fig3 - levetiracetam fig3

levetiracetam-fig4 - levetiracetam fig4

levetiracetam-fig4 - levetiracetam fig4

levetiracetam-fig5 - levetiracetam fig5

levetiracetam-fig5 - levetiracetam fig5

figure6 - levetiracetam figure6

figure6 - levetiracetam figure6

This is a table showing the percentage of patients in a study who were either given a placebo or Levetiracetam tablets. The data is not enough to give more information.*

str - levetiracetam str

str - levetiracetam str

levetiracetam_1000 - levetiracetam 1000 60

levetiracetam_1000 - levetiracetam 1000 60

This text provides information on usage instructions for a medication called Levetiracetam Tablets USP. It advises the pharmacist to store it in a child-resistant and light-resistant container at a controlled room temperature of 25°C, with minor temperature excursions being acceptable. The dosage recommendation details should be consulted from the package insert. This medication is marketed by Ajanta Pharma USA Inc from Bridgewater, NJ, and manufactured by Ajanta Pharma Limited from India. A medication guide is also included to be dispensed with the medication.*

levetiracetam_250mg - levetiracetam 250 120

levetiracetam_250mg - levetiracetam 250 120

This is a medication description for Levetiracetam tablets. The recommended storage temperature and conditions are given, as well as dosage recommendations which can be found in the accompanying package insert. The medication should be dispensed in a container with a child-resistant closure, and with an attached medication guide. The tablets are manufactured by Ajanta Pharma Limited in India and each film coated tablet contains 250 mg of Levetiracetam USP. The product code is MH/DRUGS/AD/018 and the NDC is 27241-007-12 for the 120 tablets.*

levetiracetam_500mg - levetiracetam 500 120

levetiracetam_500mg - levetiracetam 500 120

This text is a medication label for Levetiracetam Tablets USP with dosage and storage recommendations. It instructs the pharmacist to dispense in a container with a child-resistant closure and provides the code no. and the manufacturer's details. It includes a medication guide and NDC number for easy identification. The tablet contains Levetiracetam USP 500 mg.*

levetiracetam_750mg - levetiracetam 750 120

levetiracetam_750mg - levetiracetam 750 120

This is a medication guide for a drug called Levetiracetam Tablets USP, which comes in a container with 120 tablets. It is recommended to store the tablets in a tight, light-resistant container with a child-resistant closure at a temperature of 25°C (77°F), with excursions permitted to 15-30°C (59-86°F). The medication guide is attached and the usual dosage must be checked from the package insert for complete dosage recommendations. The drug is manufactured by Ajanta Pharma Limited in India and marketed by Ajanta Pharma USA Inc. in Bridgewater, NJ. The tablets contain 750 mg of Levetiracetam USP.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.